Topic: FDA, Testing, Coronavirus

Suspicious timing of Pfizer vaccine announcement November 26, 2020 Michael Nadler We are owed an explanation of why earlier interim analyses that were planned were dropped, thanks to decisions that were made by Pfizer and the FDA despite the early data meeting agreed-upon criteria of efficacy.